We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations

This study has suspended participant recruitment.
(Other - Review of screening procedures for Ph-like testing)
Sponsor:
ClinicalTrials.gov Identifier:
NCT02883049
First Posted: August 30, 2016
Last Update Posted: November 16, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
National Cancer Institute (NCI)
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Study Completion Date: No date given
  Estimated Primary Completion Date: August 30, 2021 (Final data collection date for primary outcome measure)